Are autophagic Markers BECLIN 1 and LC3 Associated with Prognosis of Multiple Myeloma?
The results of this study suggest that higher immunoreactivity for autophagic markers in MM is associated with superior patient survival.
Arthritis trials have been reported inadequately in relation to meta-analysis. As most trials are underpowered, meta-analysis is indispensable and the deficit therefore needs urgent improvement. Investigators should specify a priori what constitutes an important treatment effect and report numbers of patients improved.